The table below shows Arcutis Biotherapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$105.40M
$99.22M
$81.50M
$65.85M
$44.76M
$30.86M
Cost of revenue
$9.78M
$8.69M
$7.49M
$8.83M
$5.50M
$3.46M
Gross profit
-
-
-
-
-
-
R&D
$30.63M
$19.60M
$19.45M
$17.54M
$19.50M
$19.30M
ARQT annual revenue (10-K history)
Arcutis Biotherapeutics, Inc. reported annual revenue of $376.07M for fiscal year 2025. That is up 91.3% from $196.54M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.